Presentation TCT 2022 NEXT STEPS: How Will Renal Denervation be Implemented in Practice? Presenter: Naomi Fisher September 18, 2022
Presentation TCT 2022 Clinical Implications of RADIANCE II and Recent Renal Denervation Trials: A Clinician’s Perspective Presenter: Patrick O'Gara September 18, 2022
Presentation TCT 2022 Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial Presenter: Deepak Bhatt September 18, 2022
Presentation TCT 2022 Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Primary Results of the Randomized, Sham-Controlled RADIANCE II Pivotal Trial Presenter: Ajay Kirtane September 18, 2022
Presentation TCT 2022 TCT 736: Saline Optical Coherence Tomography (OCT) to guide revascularizationin in a patient with severe renal impairment and multivessel coronary artery disease. Presenter: George Besis September 18, 2022
Presentation TCT 2022 Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation) Presenter: Naomi Fisher September 17, 2022
Presentation TCT 2022 Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation) Presenter: David Kandzari September 17, 2022
Presentation TCT 2022 TCT 215: Association between Renal Sympathetic Denervation and Arterial Stiffness: the ASORAS Study. Presenter: Victor Zeijen September 17, 2022
Presentation TCT 2022 TCT 214: Single Ablation Renal Denervation – The RADAR Study Experience with the Metavention iRF System Presenter: Horst Sievert September 17, 2022
Presentation TCT 2022 TCT 212: Twenty-Four Month Results in Patients with Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial Presenter: Roland Schmieder September 17, 2022
Presentation TCT 211: Home Blood Pressure Response to Ultrasound Renal Denervation - a Patient-level Pooled Analysis of the RADIANCE-HTN SOLO and TRIO Randomised, Sham-controlled Trials Presenter: Andrew Sharp September 17, 2022
Presentation TCT 2022 TCT 213: Impact of Cardiac Neuromodulation Therapy (CNT) on Systolic Blood Pressure and Pulse Pressure in Hypertensive Patients Indicated for a Pacemaker: Results of a Crossover Study Presenter: Daniel Burkhoff September 17, 2022
Presentation TCT 2022 TCT 210: Long-term blood pressure results after renal sympathetic denervation using endovascular ultrasound Presenter: Karl Fengler September 17, 2022
Presentation TCT 2022 TCT 807: IVUS-Guided Complex Left Main Bifurcation Intervention With Rotational Atherectomy Using Ultra-Low Contrast in a Patient With Renal Impairment Presenter: TAWFIQ CHOUDHURY September 17, 2022
Presentation EuroPCR 2022 Blood pressure and MACE reductions after renal denervation: 3-year GSR results Presenter: Felix Mahfoud May 20, 2022
Presentation Fellows 2022 Peripheral Case Potpourri: Head to Toe (Includes Carotid, Renal, and CLI) Presenter: Babak Hassid May 07, 2022
Presentation ARCH 2022 Current Status and Future of Renal Denervation for Hypertension Presenter: Tim A. Fischell April 23, 2022
Presentation ACC 2022 Long Term Efficacy and Safety of Renal Denervation on Blood Pressure in Patients on Antihypertension Medications: 3-Year Outcomes from the SPYRAL HTN-ON MED Trial Presenter: Felix Mahfoud April 04, 2022
Presentation THT 2022 Second Heart -- Enhanced Renal Artery Perfusion for Chronic Heart Failure Presenter: leslie miller February 02, 2022
Presentation THT 2022 Revamp - Infra-Renal Vein Partial Occlusion for ADHF Presenter: Lihu Avitov February 02, 2022